The co-occurrence of anti-CCP positive RA with IgA nephropathy
DOI:
https://doi.org/10.15305/ijrci/v8i1/342Abstract
Very few studies have explored the renal involvement in RA. This co-occurrence could be attributed to the disease itself or drug induced. The present case study discussing the co-occurrence of anti-CCP positive RA and IgA nephropathy highlights the need for having a collaborative treatment approach for managing the patients.
References
Muthukumar P, Dhanapriya J, Gopalakrishnan N, Dineshkumar T, Sakthirajan R, Balasubramaniyan T. Evaluation of renal lesions and clinicopathologic correlation in rheumatoid arthritis. Saudi Journal of Kidney Diseases and Transplantation. 2017 Jan 1;28(1):44.
Kanevskaia MZ, Varshavskiĭ VA. [The problem of rheumatoid nephropathy]. Ter Arkh. 2003;75(5):24–9.
Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, et al. The Pathophysiology of IgA Nephropathy. J Am Soc Nephrol. 2011 Oct;22(10):1795–803.
Galesić K, Prkacin I, Tisljar M, Vergles JM. [Renal involvement in patients with rheumatoid arthritis]. Reumatizam. 2009;56(1):30–5.
Icardi A, Araghi P, Ciabattoni M, Romano U, Lazzarini P, Bianchi G. Kidney involvement in rheumatoid arthritis. Reumatismo. 2003;76–85.
Anders H-J, Vielhauer V. Renal co-morbidity in patients with rheumatic diseases. Arthritis Res Ther. 2011;13(3):222.
Premužić V, Padjen I, Cerovec M, Ćorić M, Jelaković B, Anić B. The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes. Haase-Fielitz A, editor. Case Reports in Nephrology. 2020 Apr 21;2020:9480860.
Piga M, Chessa E, Ibba V, Mura V, Floris A, Cauli A, et al. Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort. Autoimmun Rev. 2014 Aug;13(8):873–9.
Published
Issue
Section
License
Copyright for articles published in this journal is retained by the authors, with first publication rights granted to the ‘Internet Journal of Rheumatology and Clinical Immunology’. All the published content, except where otherwise noted, is licensed under Creative Commons license (CC-BY).
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication of the manuscript in IJRCI, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
